Thibault Renard/iStock via Getty Images Eli Lilly (LLY) and Regeneron Pharmaceuticals (REGN) are among seven drug companies selected by the US FDA to become a part of the FDA PreCheck Pilot Program, which is designed to improve US drug manufacturing capabilities. The program provides “earlier FDA Source link Like this:Like Loading… Related Post navigation GMEX Robotics approves 1-for-9 reverse stock split; shares down (NASDAQ:GMEX) Regulator should reject NextEra-Dominion power megadeal, senator says (NEE:NYSE)
